Escutia-Cuevas Héctor Hugo, Alcantara Melendez Marco, Jiménez-Valverde Arnoldo Santos, Zaragoza-Rodriguez Gregorio, Vargas-Cruz Antonio, Garcia-Garcia Juan Francisco, Ordonez-Salazar Bayardo Antonio, Flores-Morgado Antonio, Orozco Guerra Guillermo, Renteria-Valencia Diego Alvaro
Department of Interventional Cardiology, National Medical Center, Mexico City, Mexico.
Acta Cardiol. 2023 Feb;78(1):55-63. doi: 10.1080/00015385.2021.2015546. Epub 2022 Jan 4.
Distal transradial access (dTRA) as a refinement of the conventional transradial access (TRA) has advantages in terms of risk of radial artery occlusion (RAO). In order to evaluate the real-world feasibility and safety of dTRA as the default access site for routine coronary angiography (CAG) and percutaneous coronary intervention (PCI) in a Latin-American centre, this prospective observational registry was conducted.
Consecutive patients with a prior assessment for CAG and/or PCI were enrolled in this single-centre prospective registry from October 2018 to March 2019. The primary endpoints were the success rate of CAG and PCI. Secondary endpoints included the success rate of puncture of the distal radial artery, complications at the puncture site and puncture time.
The success rates of CAG and PCI were 100% (155/155) and 97% (69/71), respectively. Puncture time and fluoroscopic time were 52 ± 19 seconds and 16.3 ± 35.4 minutes, respectively. Haemostasis time was 142 ± 45 min. A total of 19 (12.5%) puncture site complications occurred, including 18 (11.6%) minor haematomas and one (0.6%) arterial perforation, in which the artery was patent at the one-month follow-up. Five patients complained of left thumb numbness at a one-month follow-up. No distal radial artery occlusion, pseudoaneurysm, or arteriovenous fistula occurred.
The success and complication rates of ldTRA support the feasibility and safety of this procedure using the appropriate materials in previously selected patients.
作为传统经桡动脉途径(TRA)的改良方法,远端经桡动脉途径(dTRA)在桡动脉闭塞(RAO)风险方面具有优势。为了评估在拉丁美洲中心将dTRA作为常规冠状动脉造影(CAG)和经皮冠状动脉介入治疗(PCI)的默认穿刺部位在现实世界中的可行性和安全性,开展了这项前瞻性观察性注册研究。
2018年10月至2019年3月,将先前接受过CAG和/或PCI评估的连续患者纳入该单中心前瞻性注册研究。主要终点是CAG和PCI的成功率。次要终点包括桡动脉远端穿刺成功率、穿刺部位并发症及穿刺时间。
CAG和PCI的成功率分别为100%(155/155)和97%(69/71)。穿刺时间和透视时间分别为52±19秒和16.3±35.4分钟。止血时间为142±45分钟。共发生19例(12.5%)穿刺部位并发症,包括18例(11.6%)小血肿和1例(0.6%)动脉穿孔,其中1个月随访时动脉仍通畅。5例患者在1个月随访时诉左拇指麻木。未发生桡动脉远端闭塞、假性动脉瘤或动静脉瘘。
在先前选择的患者中使用合适的材料,dTRA的成功率和并发症发生率支持该操作的可行性和安全性。